Background
==========

Since the initial reports on disease-predisposing mutations in the mismatch-repair (MMR) genes *MLH1* \[MIM:120436\], *MSH2* \[MIM:609309\] and *MSH6* \[MIM:600678\] in the early 1990'ies, a large number of studies have contributed to the establishment of the molecular map of Lynch syndrome with over 3,072 unique genetic MMR gene variants identified. These data are predominantly based on studies from North America, Europe and Asia. The mutations affect *MLH1* in 42%*, MSH2* in 33%, *MSH6* in 18% and *PMS2* in 8% \[[@B1]\]. Nonsense mutations, frameshift mutations and missense mutations predominate, whereas large genomic rearrangements and splice-site variants constitute \<10% of the alterations \[[@B1]\].

The South American population is ethnically mixed from American Indian and European ancestors. In Uruguay and Argentina, European ancestry predominates. In Brazil, significant African and American Indians roots apply. In Chile, Colombia, Peru and Bolivia, Spanish colonist and American Indian ancestry influence the populations \[[@B2],[@B3]\]. Mutation screening in South American families suspected of Lynch syndrome has identified disease-predisposing germline mutations in *MLH1* and *MSH2* in 16-45% of families that fulfill the Amsterdam criteria and/or the Bethesda guidelines \[[@B2]-[@B7]\]. Hereditary colorectal cancer registries have been established in Argentina, Brazil, Uruguay and Chile with the aim to collect and share data on the MMR gene mutation spectrum, identify potential founder mutations, interpret the role of unclassified genetic variants and to study cancer risks in the South American Lynch syndrome population. We used published data and unpublished register data to describe the mutation spectrum in South American Lynch syndrome families.

Methods
=======

Ethics statement
----------------

All patients provided an informed consent for inclusion into the South American registers during genetic counseling sessions and is in compliance with the Helsinki Declaration.

Patient selection
-----------------

Families that fulfilled the Amsterdam criteria \[[@B8],[@B9]\] and/or the Bethesda guidelines \[[@B10]\] were selected from the hereditary cancer registries at the Hospital Italiano (Buenos Aires, Argentina), the Hospital de las Fuerzas Armadas (Montevideo, Uruguay), the Clinica Los Condes (Santiago, Chile), the Barretos Cancer Hospital (Barretos, Brazil) and from two databases in Colombia and in Southeastern Brazil (Figure [1](#F1){ref-type="fig"}, Table [1](#T1){ref-type="table"}) \[[@B2],[@B3],[@B5],[@B11]\]. Patients were informed about their inclusion into the registries, which generally contained data on family history, age at onset and results of genetic testing.

![Flowchart of South American patients/families included in the study.](1897-4287-11-18-1){#F1}

###### 

Summary of register data from MMR South American Lynch syndrome families

              **South American Institutions**              **Total number of patients/families**   **MMR mutation carriers**   **% of MMR mutation carriers**   **Mean age at CRC diagnosis**   **Mean age at endometrial cancer diagnosis**
  ------------------------------------------------------- --------------------------------------- --------------------------- -------------------------------- ------------------------------- ----------------------------------------------
        Hospital Italiano (Buenos Aires, Argentina)                         28                                14                            50.0                        44.3 (SD 6.2)                          46.3 (SD 5.5)
   Hospital de las Fuerzas Armadas (Montevideo, Uruguay)                    25                                 7                            28.0                        35.1 (SD 7.6)                          41.5 (SD 8.3)
          Clinica Las Condes^a^ (Santiago, Chile)                           50                                20                            40.0                       35.7 (SD 10.7)                          41.1 (SD 8.8)
      Barretos Cancer Hospital^a^ (Barretos, Brazil)                        23                                15                            65.2                       39.4 (SD 13.8)                          49.8 (SD 5.3)
                        Colombia^c^                                         13                                 8                            61.5                             NA                                      NA
                  Southeastern Brazil^b^                                    128                               35                            27.3                       42.3 (SD 11.4)                          48.8 (SD 2.4)
                          *Total*                                           267                               99                            37.1                                                                      

^a^MLPA analysis included, ^b^Valentin et al. 2011 \[[@B3]\] and Rossi et al. 2002 \[[@B5]\], ^c^Giraldo et al. 2005 \[[@B2]\] and Alonso-Espinaco et al. 2011 \[[@B11]\], *NA* Information not available, *MMR* mismatch-repair genes, *SD* standard deviation, *CRC* colorectal cancer.

Disease-predisposing mutations
------------------------------

Methods to assess MMR status, e.g. microsatellite instability analysis and MMR protein staining, varied between the countries and were excluded from the present study since these data were incomplete. Molecular diagnosis was generally based on direct sequencing of *MLH1* and *MSH2*. Chilean and Brazilian families were also analyzed for large genomic rearrangements using the multiplex ligation-dependent probe amplification (MLPA) method (performed using the SALSA kit P003, MRC-Holland, Amsterdam, Netherlands).

Mutation nomenclature
---------------------

Mutation nomenclature was in accordance with the Human Genome Variation Society (HGVS) guidelines \[[@B12]\]. Mutations in the *MLH1* or *MSH2* genes were considered deleterious if they: a) were classified as pathogenic in LOVD database; b) introduced a premature stop codon in the protein sequence (nonsense or frameshift mutation); c) occurred at donor or acceptor splice sites; or d) represented whole-exon deletions or duplications. All identified mutations were correlated to the MMR Gene Unclassified Variants Database (<http://www.mmruv.info>), the Mismatch Repair Genes Variant Database (<http://www.med.mun.ca/mmrvariants/>), the French MMR network (<http://www.umd.be/MMR.html>) and the International Society for Gastrointestinal Hereditary Tumors (InSIGHT) (<http://www.insight-group.org>).

Variants of uncertain significance
----------------------------------

To establish the pathogenicity of variants of uncertain significance, web-based programs, i.e. Polyphen, MAPP-MMR, SIFT, P-mut and PON-MMR were applied to predict the effect of an amino acid substitution based on protein structural change and/or evolutionary conservation \[[@B13]-[@B17]\].

Statistical analysis
--------------------

The statistical analyses were performed using the statistical software package IBM SPSS Statistics 20 (SPSS, Chicago, IL, USA).

Results
=======

In total, 110 families harbored MMR gene variants, of which 99 were classified as Lynch syndrome predisposing and 11 were regarded as variants of uncertain significance. Mutations in *MLH1* and *MSH2* were identified in 37% (range 27-65% in the different countries/registries) of the families that fulfilled the Amsterdam criteria and/or Bethesda guidelines (Table [1](#T1){ref-type="table"}). When the Amsterdam criteria were considered, the mutation detection rate was 55% (81/147), whereas 15% families that fulfilled the Bethesda guidelines had disease-predisposing mutations. The mean age at diagnosis was 35--44 years for colorectal cancer and 41--49 years for endometrial cancer in the different registries (Table [1](#T1){ref-type="table"}). Pedigree information was available from 54 families and showed that among the Lynch syndrome-associated tumors, 65% were colorectal cancers (of which 43% were located in the right side of the colon), 22% endometrial cancers and 13% constituted other Lynch syndrome-associated cancer types.

Of the 99 disease-predisposing MMR gene mutations, 60% affected *MLH1* and 40% affected *MSH2* (Table [2](#T2){ref-type="table"}). Frameshift and nonsense mutations were the most common alterations (36% and 31%, respectively), followed by splice site mutations (13%), missense mutations (12%) and large deletions (8%) (Figure [2](#F2){ref-type="fig"}a)*.* Though the mutations were spread over the genes, hot-spot regions included exons 16 and 18 in *MLH1* (13% of the mutations each) and exon 13 in *MSH2* (24% of the mutations each) (Figure [2](#F2){ref-type="fig"}b).

###### 

Spectrum of alterations in South American Lynch syndrome families

  **Gene**                     **Nucleotide**               **Consequence**      **Exon**        **Reported as**           **Country**   **Number of families**                   **References**
  ---------------------------- ---------------------------- -------------------- --------------- ------------------------- ------------- ---------------------------------------- --------------------------
  *MLH1*                       c.1-?\_116 + ?del            p.M1_C39 \> FfsX13   1               Causal                    Chile         2                                        InSIGHT
  c.199G \> A                  p.G67R                       2                    Causal          Argentina                 1             InSIGHT                                  
  c.211G \> T                  p.E71X                       3                    Causal          Brazil                    1             InSIGHT                                  
  c.289 T \> G                 p.Y97D                       3                    VUS             Uruguay                   1             InSIGHT                                  
  C.336 T \> A                 p.H112Q                      4                    VUS             Argentina                 1             InSIGHT                                  
  c.350C \> T                  p.T117M                      4                    Causal          Uruguay                   2             InSIGHT                                  
  c.421C \> G                  p.P141A                      5                    VUS             Colombia                  1             Giraldo et al. 2005 \[[@B2]\]            
  c.503dupA                    p.N168KfsX4                  6                    Causal          Chile                     1             InSIGHT                                  
  c.503delA^a^                 p.N168IfsX34                 6                    Causal          Brazil                    1             Not previously described                 
  c.545 + 3A \> G                                           6                    Causal          Brazil                    2             InSIGHT                                  
  c.588 + 2 T \> A^a^                                       7                    Causal          Brazil                    1             Valentin et al. 2011 \[[@B3]\]           
  c.588 + 5G \> C                                           7                    Causal          Brazil                    1             InSIGHT                                  
  c.665delA                    p.N222MfsX7                  8                    Causal          Uruguay                   2             InSIGHT                                  
  c.676C \> T                  p.R226X                      8                    Causal          Argentina                 1             InSIGHT                                  
  c.677G \> A                  p.R226Q                      8                    Causal          Argentina, Brazil         3             InSIGHT                                  
  c.677 + 5G \> A                                           8                    Likely causal   Chile                     1             French MMR network                       
  c.779 T \> G                 p.L260R                      9                    Causal          Brazil                    1             InSIGHT                                  
  c.790 + 1G \> A                                           9                    Causal          Chile, Colombia           3             InSIGHT                                  
  c.791-6_793delgtttagATC^a^                                10                   Causal          Brazil                    1             Valentin et al. 2011 \[[@B3]\]           
  c.794G \> C                  p.R265P                      10                   VUS             Chile                     1             InSIGHT                                  
  c.901C \> T                  p.Q301X                      11                   Causal          Chile                     1             InSIGHT                                  
  c.1013A \> G^a^              p.N338S                      11                   VUS             Brazil                    1             InSIGHT                                  
  c.1038 + 1G \> T^a^          p.Y347FfsX13                 11                   Causal          Chile                     1             Wielandt et al. 2012                     
  c.1039-8T_1558?896Tdup^a^    p.520Vfs564X                 12 to 13             Causal          Colombia                  2             Alonso-Espinaco et al. 2011 \[[@B11]\]   
  c.1276C \> T                 p.Q426X                      12                   Causal          Brazil                    3             InSIGHT                                  
  c.1459C \> T                 p.R487X                      13                   Causal          Brazil                    1             InSIGHT                                  
  c.1499_1501delTCA^a^         p.I500del                    13                   Causal          Brazil                    1             Rossi et al. 2002 \[[@B5]\]              
  c.1558 + 1G \> T                                          13                   Causal          Brazil                    1             InSIGHT                                  
  c.1558 + 14G \> A                                         13                   VUS             Colombia                  2             InSIGHT                                  
  c.1559-2A \> C                                            13                   Causal          Chile                     1             InSIGHT                                  
  c.1559-?\_1731 + ?del        p.V520_S577 \> GfsX7^b^      14 -15               Causal          Chile                     1             Wielandt et al. 2012                     
  c.1639_1643dup TTATA^a^      p.L549YfsX44                 14                   Causal          Brazil                    1             Valentin et al. 2011 \[[@B3]\]           
  c.1690_1693delCTCA           p.L564FfsX26                 15                   Causal          Brazil                    1             InSIGHT                                  
  c.1724G \> A                 p.R575K                      15                   VUS             Argentina                 1             InSIGHT                                  
  c.1731 + 3A \> T^a^          Skipping exon 15             15                   Causal          Chile                     1             Alvarez et al. 2010 \[[@B6]\]            
  c.1846delAAG                 p.K616del                    16                   Causal          Argentina                 1             InSIGHT                                  
  c.1852_1853delinsGC          p.K618A                      16                   Causal          Argentina                 1             InSIGHT                                  
  c.1852_1854 delAAG           p.K618del                    16                   Causal          Argentina                 1             InSIGHT                                  
  c.1853A \> C                 p.K618T                      16                   VUS             Brazil                    1             InSIGHT                                  
  c.1853delAinsTTCTT^a^        p.K618IfsX4                  16                   Causal          Brazil                    2             Valentin et al. 2011 \[[@B3]\]           
  c.1856delG^a^                                             16                   Causal          Colombia                  2             Giraldo et al. 2005 \[[@B2]\]            
  c.1890dup^a^                 p.D631fsX1                   16                   Causal          Argentina                 1             Valentin et al. 2011 \[[@B3]\]           
  c.1897-?\_1989 + ?del^a^                                  17-19                Causal          Brazil                    1             Not previously described                 
  c.1918C \> T                 p.P640T                      17                   VUS             Colombia                  1             InSIGHT                                  
  c.1975C \> T                 p.R659X                      17                   Causal          Brazil                    1             InSIGHT                                  
  c.1998G \> A                 p.W666X                      18                   Causal          Brazil                    1             Rossi et al. 2012 \[[@B5]\]              
  c.2027 T \> C                p.L676P                      18                   Causal          Brazil                    1             InSIGHT                                  
  c.2041G \> A                 p.A681T                      18                   Likely causal   Chile, Brazil, Colombia   4             French MMR network                       
  c.2092_2093delTC             p.S698RfsX5                  18                   Causal          Chile                     1             Alvarez et al. 2010 \[[@B6]\]            
  c.2224C \> T^a^              p.Q742X                      19                   Causal          Brazil                    1             Valentin et al. 2011 \[[@B3]\]           
  c.2252_2253dupAA             p.V752KfsX26                 19                   VUS             Brazil                    1             InSIGHT                                  
  c.2104-?\_2271 + ?del^b^     p.S702_X757del               19                   Causal          Chile                     2             Wielandt et al. 2012                     
  *MSH2*                       c.71delA^a^                  p.Q24fs              1               Causal                    Brazil        1                                        Not previously described
  c.166G \> T^a^               p.E56X                       1                    Causal          Argentina                 1             InSIGHT                                  
  c.174dupC^a^                                              1                    Causal          Brazil                    1             Not previously described                 
  c.175dupC^a^                 p.K59QfsX23                  1                    Causal          Brazil                    1             Valentin et al. 2011 \[[@B3]\]           
  c.181C \> T^a^               p.Q61X                       1                    Causal          Uruguay                   1             Sarroca et al. 2003                      
  c.187delG                    p.V63fsX1                    1                    Causal          Brazil                    1             InSIGHT                                  
  c.289C \> T                  p.Q97X                       2                    Causal          Argentina                 1             InSIGHT                                  
  c.212-?\_366 + ?del          p.A72_K122 \> FfsX9          2                    Causal          Chile                     1             InSIGHT                                  
  c.388_389delCA               p.Q130VfsX2                  3                    Causal          Brazil, Argentina         2             InSIGHT                                  
  c.530_531delAA^a^            p.E177fsX3                   3                    Causal          Uruguay                   1             Sarroca et al. 2003                      
  c.596delTG^a^                                             3                    Causal          Colombia                  1             Giraldo et al. 2005 \[[@B2]\]            
  c.862C \> T                  p.Q287X                      5                    Causal          Brazil                    1             InSIGHT                                  
  c.897 T \> G                 p.Y299X                      5                    Causal          Chile                     1             Wielandt et al. 2012                     
  c.942 + 3 A \> T                                          5                    Causal          Brazil                    1             InSIGHT                                  
  c.1077-?\_1276 + ?del        p.L360KfsX16                 7                    Causal          Argentina                 1             InSIGHT                                  
  c.1147C \> T                 p.R382X                      7                    Causal          Brazil                    1             InSIGHT                                  
  c.1215C \> A                 p.Y405X                      7                    Causal          Chile                     1             InSIGHT                                  
  c.1216C \> T                 p.R406X                      7                    Causal          Uruguay                   1             InSIGHT                                  
  c.1249delG                   p.V417LfsX21                 7                    Causal          Brazil                    1             InSIGHT                                  
  c.1255C \> T                 p.Q419X                      7                    Causal          Brazil                    1             InSIGHT                                  
  c.1444A \> T^a^              p.R482X                      9                    Causal          Brazil                    1             Valentin et al. 2011 \[[@B3]\]           
  c.1447G \> T                 p.E483X                      9                    Causal          Brazil                    2             InSIGHT                                  
  c.1667delT^a^                p.L556X                      11                   Causal          Brazil                    1             Valentin et al. 2011 \[[@B3]\]           
  c.1667_1668insA^a^           p.T557DfsX5                  11                   Causal          Brazil                    1             Rossi et al. 2002 \[[@B5]\]              
  c.1910delC^a^                p.R638GfsX47                 12                   Causal          Argentina                 1             Vaccaro et al. 2007                      
  c.1967_1970dupACTT^a^        p.F657LfsX3                  12                   Causal          Brazil                    1             Valentin et al. 2011 \[[@B3]\]           
  c.2038C \> T                 p.R680X                      13                   Causal          Chile                     1             InSIGHT                                  
  c.2046_2047delTG^a^          p.V684Dfs\*14                13                   Causal          Argentina                 1             InSIGHT                                  
  c.2131C \> T                 p.R711X                      13                   Causal          Brazil                    1             InSIGHT                                  
  c.2152C \> T                 p.Q718X                      13                   Causal          Brazil                    6             InSIGHT                                  
  c.2185_2192del7insCCCT^a^    p.M729_E731delinsP729_X730   13                   Causal          Chile                     1             Alvarez et al. 2010 \[[@B6]\]            
  c.2187G \> T^a^              p.M729I                      13                   VUS             Brazil                    1             Valentin et al. 2011 \[[@B3]\]           
  c.2525_2526delAG^a^          p.E842VfsX3                  15                   Causal          Brazil                    2             Valentin et al. 2011 \[[@B3]\]           
  c.2785C \> T^a^              p.R929X                      16                   Causal          Brazil                    1             Valentin et al. 2011 \[[@B3]\]           

^a^First reported, *VUS* variants of unclassified significance, MLH1 (MIM\#120436), MSH2 (MIM\#609309),^b^pathogenecity demonstration ongoing.

![**Spectrum of pathogenic mutations in*MLH1*and*MSH2*genes a) Types of pathogenic germline mutations; b) Distribution along all exons of the*MMR*genes.**](1897-4287-11-18-2){#F2}

In total, 10 mutations identified in at least two South American families were classified as recurrent. Among these, the *MSH2* c.2152C \> T identified in Brazil represents an internationally hot-spot. Three founder mutations were identified in five South American families. The *MLH1* c.545 + 3A \> G and the *MSH2* c.942 + 3A \> T have been identified as founder mutations in Italy and in Newfoundland and were also identified in Brazilian families \[[@B3]\]. The *MLH1* c.1039-8T_1558 + 896Tdup has been suggested to represent a founder mutation in Colombia \[[@B2],[@B11]\]. Mutations that were unique and herein first reported in more than one family included the *MLH1* c.1853delAinsTTCTT in Brazil, the *MLH1* c.1856delG in Colombia and the *MSH2* c.25252_2526delAG in Brazil (Table [2](#T2){ref-type="table"}) (Figure [3](#F3){ref-type="fig"}).

![**Map of South America showing the countries where Lynch syndrome families with the founder, recurrent, unique mutations and variants of unclassified significance (VUS) have been identified.** The figure depicts the countries participating in the study (gray). The pie chart represents in percentage the recurrent mutations, unique mutations, founder mutations and VUS identified in the South American families. Brazil is characterized by 16% of the founder mutations, 39% of the recurrent mutations, 14% of the unique mutations and 31% of the VUS, while Colombia by 20% of the founder mutations, 20% of the unique mutations and 60% of the VUS. Chile, Argentina and Uruguay are characterized by 80%, 50% and 67% of the recurrent mutations and 20%, 50% and 33% of the VUS, respectively.](1897-4287-11-18-3){#F3}

In total, 11 variants of unclassified significance were identified in individuals from Argentina, Uruguay, Chile, Brazil and Colombia (Table [3](#T3){ref-type="table"}) \[[@B2],[@B3]\]. *In silico* analysis suggested that the *MLH1* c.289 T \> G, the *MLH1*c.794G \> C and the *MLH1*c.1918C \> T were likely disease-predisposing (Table [3](#T3){ref-type="table"}).

###### 

Variants of unclassified significance and in silico prediction in South American Lynch syndrome families

  **Country**   **Gene**   **Nucleotide**      **Consequence**   **Exon**   **Polyphen**   **SIFT**            **MAP_MMR**   **P-mut**   **PON-MMR**                                                           
  ------------- ---------- ------------------- ----------------- ---------- -------------- ------------------- ------------- ----------- ------------- ------------------------ -------- -------------- ------ ------------
  Uruguay       *MLH1*     c.289 T \> G        p.Y97D            3          0.999          Probably damaging   0             Damaging    10.51         Damaging                 0.7266   Pathological   0.83   Pathogenic
  Argentina     *MLH1*     c.336 T \> A        p.H112Q           4          1              Probably damaging   0.03          Damaging    2.430         Neutral                  NA       NA             0.61   VUS
  Colombia      *MLH1*     c.421C \> G         p.P141A           5          0.329          Benign              0.05          Damaging    3.15          Borderline deleterious   0.4928   Neutral        0.48   VUS
  Chile         *MLH1*     c.794G \> C         p.R265P           10         1              Probably damaging   0             Damaging    38.09         Damaging                 0.7623   Pathological   0.83   Pathogenic
  Brazil        *MLH1*     c.1013A \> G        p.N338S           11         0.506          Possibly Damaging   0.05          Damaging    2.78          Neutral                  0.2551   Neutral        0.38   VUS
  Colombia      *MLH1*     c.1558 + 14G \> A                     13         NA             NA                  NA            NA          NA            NA                       NA       NA             NA     NA
  Argentina     *MLH1*     c.1724G \> A        p.R575K           15         0.001          Benign              0.40          Tolerated   1.490         Neutral                  NA       NA             0.15   Neutral
  Brazil        *MLH1*     c.1853A \> C        p.K618T           16         0.997          Probably damaging   0.02          Damaging    5.11          Damaging                 0.7802   Pathological   0.67   VUS
  Colombia      *MLH1*     c.1918C \> T        p.P640T           17         1              Probably damaging   0             Damaging    17.77         Damaging                 0.6534   Pathological   0.83   Pathogenic
  Brazil        *MLH1*     c.2252_2253dupAA    p.V752Kfs\*26     19         NA             NA                  NA            NA          NA            NA                       NA       NA             NA     NA
  Brazil        *MSH2*     c.2187G \> T        p.M729I           13         2.293          Probably damaging   0             Damaging    21.99         Damaging                 0.1988   Neutral        0.71   VUS

MLH1 (MIM\#120436), MSH2 (MIM\#609309), NA: not applicable, VUS: variants of unclassified significance, If SIFT score \<0.05 then the aminoacid (AA) substitution is predicted to affect protein function, if PolyPhen score \>0.5 then the AA substitution is predicted to affect protein function, if MAPP-MMR score \>4.55 then the AA substitution is predicted to affect protein function, If P-mut score \> 0.5, the AA substitution is classified as pathological, if PON-MMR score \>0.7615, the AA substitution is classified as pathogenic.

Discussion
==========

In South America, disease-predisposing mutations linked to Lynch syndrome have been identified in 99 families, which corresponds to 37% of the families that fulfilled the Amsterdam criteria and/or Bethesda guidelines and underwent genetic testing. The mutation rate is high compared to prevalence rates of 28% for *MLH1* and 18% for *MSH2* in the Asian population, 31% and 20% in a multi-ethnic American population and 26% and 19% in European/Australian populations \[[@B18]\]. The mutation spectrum is predominated by *MLH1* (60%) and *MSH2* (40%) mutations \[[@B3],[@B19]-[@B22]\], but the seemingly larger contribution than the 42% and 33% reported in the InSIGHT database could reflect failure to test for *MSH6* and *PMS2* mutations in most South American studies \[[@B1]\]. Referral bias in populations that have more recently been screened for mutations represents a potential limitation, but the strong contribution from *MLH1* and *MSH2* could also reflect population structure \[[@B2],[@B4],[@B5],[@B7]\]. Frameshift mutations and nonsense mutations were the most common types of mutations, which are in agreement with findings from other populations \[[@B1],[@B23]-[@B26]\], with hotspots in exons 16 and 18 of *MLH1* and in exon 13 of *MSH2* (Figure [2](#F2){ref-type="fig"}b). Exon 16 and 18 in *MLH1* has been identified as a genetic hot spot also in other populations with 26% of the *MLH1* mutations reported herein \[[@B3],[@B18]\]. The frequent mutations in *MSH2* exon 13 may be linked to the c.2152C\>, which was first identified in Portuguese Lynch syndrome families. This alteration accounted for 35% (6/17) of the *MSH2* mutations in the Brazilian population, which is in line with the Portuguese migration to Brazil \[[@B3],[@B27]\].

Founder mutations have been identified in several populations where they significantly contribute to disease predisposition and thereby allow for directed genetic testing \[[@B28]\]. Two of the mutations identified in South American Lynch syndrome families have been suggested to constitute potential founder mutations in other populations, e.g. the Italian *MLH1* c.545 + 3A \> G and the Newfoundland *MSH2* c.942 + 3A \> T \[[@B3]\]. The Spanish founder mutations *MLH1* c.306 + 5G \> A and c.1865 T \> A and *MSH2* c.2635-3 T \> C; c2635-5C \> T; c.2063 T \> G were, however, not observed in South American Lynch syndrome families \[[@B27]-[@B30]\]. In Colombia, the *MSH2* c.1039-8T_1558 + 896Tdup was suggested to represent a founder mutation \[[@B2],[@B11]\]. The Colombian population has a mixed ancestry with a strong influence from Spanish colonists and thereby genetically differs from previously studied populations \[[@B2],[@B6]\].

Conclusions
===========

In conclusion, disease-predisposing mutations in *MLH1* and *MSH2* have been identified in a relatively large proportion of the South American families suspected of Lynch syndrome that have been tested. Genetic hot-spot regions, internationally recognized founder mutations and potential South American founder mutation have been recognized, which is of relevance for genetic counseling and testing that are increasingly available in South America.
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